231 related articles for article (PubMed ID: 34715162)
1. Predictive roles of brain-derived neurotrophic factor Val66Met polymorphism on antidepressant efficacy of different forms of prefrontal brain stimulation monotherapy: A randomized, double-blind, sham-controlled study.
Cheng CM; Hong CJ; Lin HC; Chu PJ; Chen MH; Tu PC; Bai YM; Chang WH; Juan CH; Lin WC; Tsai SJ; Su TP; Li CT
J Affect Disord; 2022 Jan; 297():353-359. PubMed ID: 34715162
[TBL] [Abstract][Full Text] [Related]
2. Antidepressant effects of prolonged intermittent theta-burst stimulation monotherapy at the bilateral dorsomedial prefrontal cortex for medication and standard transcranial magnetic stimulation-resistant major depression: a three arm, randomized, double blind, sham-controlled pilot study.
Cheng CM; Li CT; Jeng JS; Chang WH; Lin WC; Chen MH; Bai YM; Tsai SJ; Su TP
Eur Arch Psychiatry Clin Neurosci; 2023 Oct; 273(7):1433-1442. PubMed ID: 36484844
[TBL] [Abstract][Full Text] [Related]
3. Antidepressant Efficacy of Prolonged Intermittent Theta Burst Stimulation Monotherapy for Recurrent Depression and Comparison of Methods for Coil Positioning: A Randomized, Double-Blind, Sham-Controlled Study.
Li CT; Cheng CM; Chen MH; Juan CH; Tu PC; Bai YM; Jeng JS; Lin WC; Tsai SJ; Su TP
Biol Psychiatry; 2020 Mar; 87(5):443-450. PubMed ID: 31563272
[TBL] [Abstract][Full Text] [Related]
4. Task-Modulated Brain Activity Predicts Antidepressant Responses of Prefrontal Repetitive Transcranial Magnetic Stimulation: A Randomized Sham-Control Study.
Li CT; Cheng CM; Juan CH; Tsai YC; Chen MH; Bai YM; Tsai SJ; Su TP
Chronic Stress (Thousand Oaks); 2021; 5():24705470211006855. PubMed ID: 33889790
[TBL] [Abstract][Full Text] [Related]
5. Serum brain-derived neurotrophic factor, Val66Met polymorphism and open-label SSRI treatment response in Major Depressive Disorder.
Smit AJT; Wu GWY; Rampersaud R; Reus VI; Wolkowitz OM; Mellon SH
Psychoneuroendocrinology; 2024 Jul; 165():107045. PubMed ID: 38636352
[TBL] [Abstract][Full Text] [Related]
6. The longer, the better ? Longer left-sided prolonged intermittent theta burst stimulation in patients with major depressive disorder: A randomized sham-controlled study.
Li CT; Cheng CM; Lin HC; Yeh SH; Jeng JS; Wu HT; Bai YM; Tsai SJ; Su TP; Fitzgerald PB
Asian J Psychiatr; 2023 Sep; 87():103686. PubMed ID: 37406605
[TBL] [Abstract][Full Text] [Related]
7. Critical role of rhythms in prefrontal transcranial magnetic stimulation for depression: A randomized sham-controlled study.
Tsai YC; Li CT; Liang WK; Muggleton NG; Tsai CC; Huang NE; Juan CH
Hum Brain Mapp; 2022 Apr; 43(5):1535-1547. PubMed ID: 34873781
[TBL] [Abstract][Full Text] [Related]
8. Low-frequency repetitive transcranial magnetic stimulation in the right prefrontal cortex combined with partial sleep deprivation in treatment-resistant depression: a randomized sham-controlled trial.
Krstić J; Buzadžić I; Milanović SD; Ilić NV; Pajić S; Ilić TV
J ECT; 2014 Dec; 30(4):325-31. PubMed ID: 24625704
[TBL] [Abstract][Full Text] [Related]
9. Current Updates on Newer Forms of Transcranial Magnetic Stimulation in Major Depression.
Cheng CM; Li CT; Tsai SJ
Adv Exp Med Biol; 2021; 1305():333-349. PubMed ID: 33834408
[TBL] [Abstract][Full Text] [Related]
10. Two Versus One High-Frequency Repetitive Transcranial Magnetic Stimulation Session per Day for Treatment-Resistant Depression: A Randomized Sham-Controlled Trial.
Theleritis C; Sakkas P; Paparrigopoulos T; Vitoratou S; Tzavara C; Bonaccorso S; Politis A; Soldatos CR; Psarros C
J ECT; 2017 Sep; 33(3):190-197. PubMed ID: 28072660
[TBL] [Abstract][Full Text] [Related]
11. A randomized, controlled trial of sequential bilateral repetitive transcranial magnetic stimulation for treatment-resistant depression.
Fitzgerald PB; Benitez J; de Castella A; Daskalakis ZJ; Brown TL; Kulkarni J
Am J Psychiatry; 2006 Jan; 163(1):88-94. PubMed ID: 16390894
[TBL] [Abstract][Full Text] [Related]
12. International randomized-controlled trial of transcranial Direct Current Stimulation in depression.
Loo CK; Husain MM; McDonald WM; Aaronson S; O'Reardon JP; Alonzo A; Weickert CS; Martin DM; McClintock SM; Mohan A; Lisanby SH;
Brain Stimul; 2018; 11(1):125-133. PubMed ID: 29111077
[TBL] [Abstract][Full Text] [Related]
13. Bilateral theta-burst stimulation on emotional processing in major depressive disorder: A functional neuroimaging study from a randomized, double-blind, sham-controlled trial.
Chou PH; Tu CH; Chen CM; Lu MK; Tsai CH; Hsieh WT; Lai HC; Satyanarayanan SK; Su KP
Psychiatry Clin Neurosci; 2023 Apr; 77(4):233-240. PubMed ID: 36579902
[TBL] [Abstract][Full Text] [Related]
14. Comparative study of low-dose ketamine infusion and repetitive transcranial magnetic stimulation in treatment-resistant depression: A posthoc pooled analysis of two randomized, double-blind, placebo-controlled studies.
Chen MH; Cheng CM; Li CT; Tsai SJ; Lin WC; Bai YM; Su TP
Psychiatry Res; 2022 Oct; 316():114749. PubMed ID: 35940087
[TBL] [Abstract][Full Text] [Related]
15. Influence of prefrontal target region on the efficacy of repetitive transcranial magnetic stimulation in patients with medication-resistant depression: a [(18)F]-fluorodeoxyglucose PET and MRI study.
Paillère Martinot ML; Galinowski A; Ringuenet D; Gallarda T; Lefaucheur JP; Bellivier F; Picq C; Bruguière P; Mangin JF; Rivière D; Willer JC; Falissard B; Leboyer M; Olié JP; Artiges E; Martinot JL
Int J Neuropsychopharmacol; 2010 Feb; 13(1):45-59. PubMed ID: 19267956
[TBL] [Abstract][Full Text] [Related]
16. HOMA-IR increase after antidepressant treatment in depressed patients with the Met allele of the Val66Met BDNF genetic polymorphism.
Martin S; Colle R; El Asmar K; Rigal A; Vievard A; Feve B; Becquemont L; Verstuyft C; Corruble E
Psychol Med; 2019 Oct; 49(14):2364-2369. PubMed ID: 30526722
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of intermittent Theta Burst Stimulation (iTBS) and 10-Hz high-frequency repetitive transcranial magnetic stimulation (rTMS) in treatment-resistant unipolar depression: study protocol for a randomised controlled trial.
Bulteau S; Sébille V; Fayet G; Thomas-Ollivier V; Deschamps T; Bonnin-Rivalland A; Laforgue E; Pichot A; Valrivière P; Auffray-Calvier E; Fortin J; Péréon Y; Vanelle JM; Sauvaget A
Trials; 2017 Jan; 18(1):17. PubMed ID: 28086851
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of prefrontal theta-burst stimulation in refractory depression: a randomized sham-controlled study.
Li CT; Chen MH; Juan CH; Huang HH; Chen LF; Hsieh JC; Tu PC; Bai YM; Tsai SJ; Lee YC; Su TP
Brain; 2014 Jul; 137(Pt 7):2088-98. PubMed ID: 24817188
[TBL] [Abstract][Full Text] [Related]
19. High-frequency repetitive transcranial magnetic stimulation improves refractory depression by influencing catecholamine and brain-derived neurotrophic factors.
Yukimasa T; Yoshimura R; Tamagawa A; Uozumi T; Shinkai K; Ueda N; Tsuji S; Nakamura J
Pharmacopsychiatry; 2006 Mar; 39(2):52-9. PubMed ID: 16555165
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of theta burst versus high-frequency repetitive transcranial magnetic stimulation in patients with depression (THREE-D): a randomised non-inferiority trial.
Blumberger DM; Vila-Rodriguez F; Thorpe KE; Feffer K; Noda Y; Giacobbe P; Knyahnytska Y; Kennedy SH; Lam RW; Daskalakis ZJ; Downar J
Lancet; 2018 Apr; 391(10131):1683-1692. PubMed ID: 29726344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
